ĀÜĄņĀŅĀ×

Edward Benz is president and CEO emeritus of Dana-Farber Cancer Institute, director emeritus and principal investigator of the Dana-Farber/Harvard Cancer Center, and member of the Governing Board of Dana-Farber/Childrenā€™s Cancer Center. He is the Richard and Susan Smith Professor of Medicine, and Professor of Pediatrics and Pathology at Harvard Medical School.

Dr. Benz is an internationally acclaimed hematologist who is an active NIH-funded investigator on the molecular basis of blood disease; he is also an active clinician and teacher. He is co-author of three textbooks, two of which have won international awards. He has served as president of the American Society of Clinical Investigation, the American Society of Hematology, the Association of American Cancer Institutes, and the Friends of the National Institute of Nursing Research. Dr. Benz received his A.B. cum laude from Princeton University, his M.A. from Yale University, and his M.D. magna cum laude from Harvard Medical School. He has been elected to fellowship in the American Association for the Advancement of Science, the American Association of Physicians, the Institute of Medicine of the Academy of Sciences, and the American Academy of Arts and Sciences. He serves on numerous advisory boards at academic institutions, National Institutes of Health, and foundations.